Liquid biopsy firm Thrive launches with $110M Series A round
Source: http://bit.ly/2MidkkO
The company has a 10,000-patient prospective trial with Geisinger fully enrolled to test CancerSEEK, a test developed at Johns Hopkins University.
Source: http://bit.ly/2MidkkO
0 Comments